Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline C van der Hoogt

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Lipid Research|December 4, 2004
Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPLJimmy F P Berbée, Caroline C van der Hoogt, Deepa Sundararaman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 30, 2006
Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterolSabine M Post, Martine Groenendijk, Caroline C van der Hoogt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2006
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden miceMarit Westerterp, Caroline C van der Hoogt, Willeke de Haan, et al.
Journal of Lipid Research|February 12, 2008
ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiencyGery Gerritsen, Caroline C van der Hoogt, Frank G Schaap, et al.
Atherosclerosis|September 18, 2007
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP miceWilleke de Haan, Caroline C van der Hoogt, Marit Westerterp, et al.
Journal of Lipid Research|May 26, 2007
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expressionCaroline C van der Hoogt, Willeke de Haan, Marit Westerterp, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2006
Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsisJimmy F P Berbée, Caroline C van der Hoogt, Robert Kleemann, et al.
Biochimica Et Biophysica Acta|February 16, 2006
Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in miceCaroline C van der Hoogt, Jimmy F P Berbée, Sonia M S Espirito Santo, et al.
Biochemical and Biophysical Research Communications|November 11, 2008
Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivoWilleke de Haan, Ruud Out, Jimmy F P Berbée, et al.
Intensive Care Medicine|January 31, 2008
Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsisJimmy F P Berbée, Caroline C van der Hoogt, Carla J C de Haas, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Lipid Research|December 4, 2004
Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPLJimmy F P Berbée, Caroline C van der Hoogt, Deepa Sundararaman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 30, 2006
Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterolSabine M Post, Martine Groenendijk, Caroline C van der Hoogt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2006
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden miceMarit Westerterp, Caroline C van der Hoogt, Willeke de Haan, et al.
Journal of Lipid Research|February 12, 2008
ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiencyGery Gerritsen, Caroline C van der Hoogt, Frank G Schaap, et al.
Atherosclerosis|September 18, 2007
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP miceWilleke de Haan, Caroline C van der Hoogt, Marit Westerterp, et al.
Journal of Lipid Research|May 26, 2007
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expressionCaroline C van der Hoogt, Willeke de Haan, Marit Westerterp, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2006
Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsisJimmy F P Berbée, Caroline C van der Hoogt, Robert Kleemann, et al.
Biochimica Et Biophysica Acta|February 16, 2006
Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in miceCaroline C van der Hoogt, Jimmy F P Berbée, Sonia M S Espirito Santo, et al.
Biochemical and Biophysical Research Communications|November 11, 2008
Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivoWilleke de Haan, Ruud Out, Jimmy F P Berbée, et al.
Intensive Care Medicine|January 31, 2008
Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsisJimmy F P Berbée, Caroline C van der Hoogt, Carla J C de Haas, et al.
Pageof 2